|
|
| General Info |
 |
|
|
|
|
| Latest News |
- EDQM set to implement European Pharmacopoeia Version 6.8 in June 2010
European Directorate for the Quality of Medicines & HealthCare (EDQM) will
|
|
 |
|
 |
 |
|
|
 |
Event Detail |
 |
|
|
CPhI South America 2010
|
|
Location: La Rural -Hall Ocre Juncal 4431 Buenos Aires Argentina
|
|
From Date: 17-08-2010
|
|
To Date: 19-08-2010
|
|
Booth: Visiting
|
|
CPhI South America 2010 will be held in the exhibition centre La Rural. The venue is supported by a 130-year history which goes back to 1878, the year in which the third Exposición Nacional de GanaderÃa was celebrated. Its pavilions, convention halls and main auditorium are equipped with cutting-of-the-edge technology and they amount to 45,000 m2 indoors. Besides, La Rural has more than 10.000 m2 outdoors and green spaces; and a parking lot capable of hosting a thousand vehicles.
|
|
|
|
|
 |
NOTE: 
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|